from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0084/hycD

LFCtreatmentdescriptionclass of inhibitor

-0.096

Amikacinug/mL Amikacintranslation

0.468

Cap5-10ug/mL Capreomycintranslation

0.673

Rox10-50 ug/mL Roxithromycintranslation

-0.701

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

1.498

Rif0.2-5ug/mL Rifampicintranscription

-0.345

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.446

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.400

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.441

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.340

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.295

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.315

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.852

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.421

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.456

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.076

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.091

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.511

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.019

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.297

KCN5-20 ug/mL Potassium cyaniderespiration

1.095

NaN30.2-2 mM Sodium aziderespiration

-0.861

Nigericin50 uM Nigericinrespiration

0.041

TRC10-150 ug/mL Triclosanrespiration

-0.125

TRZ10-25 ug/mL Thioridazinerespiration

-0.900

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.035

menadione6-10 ug/mL Menadionerespiration

-0.458

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.275

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.093

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.589

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.831

NRP_1Non-replicating persistence stage 1dosRassociated

-0.633

Amp0.2mg/mL AmpicillincellWall

-0.438

Cephalexin20-100 ug/mL CephalexincellWall

0.913

Cerulenin0.32-5 ug/mL CerulenincellWall

0.312

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.292

EMB10-20 ug/mL EthambutolcellWall

-0.531

Eta12-40 ug/mL EthionamidecellWall

-0.417

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.350

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.191

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.098

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.187

BZA0.12 mg/mL BenzamidearomaticAmides

0.561

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.759

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.408

H2O24 mM hydrogen peroxideDNAdamaging

0.150

Levo10 ug/mL LevofloxacinDNAdamaging

0.511

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.845

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.864

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.287

UVUV-irradiationDNAdamaging

-0.286

ARP41-4 ug/mL Antitubercular compound ARP4?

0.255

Antimycin12.5-50 ug/mL Antimycin A?

-0.656

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.718

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.502

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.336

PA8240.2-2 ug/mL PA-824?

0.895

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.021

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.671

Verapamil50 uM Verapamil?

-0.504

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.776

methoxatin10-20 ug/mL Methoxatin?